Document is current
Any future updates will be listed below
-
Authors
Kliem, Paulina S. C.
Fisch, Urs
Baumann, Sira M.
Berger, Sebastian
Amacher, Simon A.
Hunziker, Sabina
Sutter, Raoul
- License Information
-
More Information
Article History
Received: 30 June 2025
Accepted: 20 August 2025
First Online: 28 August 2025
Declarations
:
: Simon Amacher is supported by the Mach-Gaensslen Foundation Switzerland and the Nora van Meeuwen-Haefliger Foundation of the University of Basel, Switzerland. Sabina Hunziker is supported by the Swiss National Foundation (SNF) (Ref 10001C_192850/1 and 10531C_182422), the Gottfried Julia Bangerter-Rhyner Foundation (8472/HEG-DSV), and the Swiss Society of General Internal Medicine (SSGIM). Raoul Sutter received research grants from the Swiss National Foundation (No 320030_169379), the Research Fund of the University Basel, the Scientific Society Basel, and the Gottfried Julia Bangerter- Rhyner Foundation. He received personal grants from UCB-pharma and holds stocks from Alcon, Johnson & Johnson, Novartis, Roche, and Sandoz. The remaining authors have no disclosures.
: Since all prompts were entirely fictional and the only person interacting with ChatGPT-3.5 was PSCK, no ethical approval was deemed necessary. With no participants included in the study, after consulting with regulatory affairs of the Department of Clinical Research of the University of Basel, a study registration was not pursued.
